Subscribe to RSS
DOI: 10.1055/s-0032-1326636
Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older
Publication History
submitted 13 January 2011
accepted after revision 22 February 2013
Publication Date:
18 June 2013 (online)

Background and study aims: Colorectal cancer (CRC) incidence ranks third among all cancers in Switzerland. Screening the general population could decrease CRC incidence and mortality. The aim of this study was to analyze the use of the fecal occult blood test (FOBT) and lower gastrointestinal endoscopy in a representative sample of the Swiss population aged ≥ 50 years.
Methods: Data were analyzed from the 2007 Swiss Health Interview Survey and the prevalence estimates and 95 % confidence intervals were calculated based on all instances of lower gastrointestinal endoscopy and FOBT use, as well as on their use for CRC screening. Uni- and multivariate logistic regression analyses were performed to describe the association between screening use and sociodemographic characteristics, indicators of healthcare system use, and lifestyle factors.
Results: In 2007, approximately 36 % of the surveyed people who were aged ≥ 50 years had previously undergone FOBT and approximately 30 % had previously undergone lower gastrointestinal endoscopy. CRC screening use was 7.7 % for FOBT (within the past year) and 6.4 % for lower gastrointestinal endoscopy (within the past 5 years). CRC screening by either method was 13 %. The major determinants of participation in CRC screening were found to be sex (male), physician visits during the past year (one or more), type of health insurance (private), and previous screening for other cancer types.
Conclusions: The results of the 2007 Swiss Health Interview Survey indicate rather low levels of FOBT and lower gastrointestinal endoscopy use. Furthermore, the results suggest disparities in the use of CRC screening.
-
References
- 1 NICER. Incidence and mortality of cancer and their evolution in Switzerland since 1983 to 2007. Available from: http://www.nicer-swiss.ch/ Last accessed: 30 April 2012
- 2 Hewitson P, Glasziou P, Irwig L et al. Screening for colorectal cancer using the fecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007; CD001216
- 3 Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624-1633
- 4 Schoen RE, Pinsky PF, Weissfeld JL et al. Colorectal cancer incidence and mortality with screening flexible sigmoidoscopy. New Engl J Med 2012; 366: 2345-2357
- 5 Arfizi C, Peytremann-Bridevaux I, Burnand B. EPAGE II Study Group et al. Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer. Endoscopy 2009; 41: 200-208
- 6 US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 627-637
- 7 Benson VS, Patnick J, Davies AK et al. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008; 122: 1357-1367
- 8 McGregor SE, Hilsden RJ, Li FX et al. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am J Gastroenterol 2007; 102: 1727-1735
- 9 Joseph DA, King JB, Miller JW et al. Prevalence of colorectal cancer screening among adults – Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep 2012; 61: 51-56
- 10 Zwahlen M. Früherkennung. In: Nationales Krebsprogramm für die Schweiz 2011–2015. Bern: Oncosuisse; 2011: 48-61 Available from: http://www.oncosuisse.ch/file/oncosuisse/nkp/2011-2015/vollversion/NKP_Vollversion_d.pdf Last accessed 13 August 2012
- 11 Institut für Markt- und Meinungsforschung. Studie betreffend die Nutzung von Mobilfunkdiensten. Lausanne: M.I.S. Trends SA; 09/2007 Available from: http://www.bakom.admin.ch/dokumentation/zahlen/00545/00722/00906/index.html?lang=de Last accessed 30 April 2012
- 12 Hamilton LC. Statistics with STATA. Updated for Version 10. Belmont, USA: Brooks/Cole, Cengage Learning; 2009: 391-412
- 13 Bundesamt für Statistik. Ständige Wohnbevölkerung nach Alter, Kanton, Bezirk und Gemeinde. 2010 Available from: http://www.bfs.admin.ch/bfs/portal/de/index/themen/01/02/blank/key/bevoelkerungsstand.html Last accessed 30 April 2012
- 14 Bundesamt für Statistik. Die Schweizerische Gesundheitsbefragung 2007 in Kürze. 10/2008 Available from: http://www.bfs.admin.ch/bfs/portal/de/index/infothek/erhebungen__quellen/blank/blank/ess/01.html Last accessed 30 April 2012
- 15 Stock C, Brenner H. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE). Endoscopy 2010; 42: 546-556
- 16 Dimitrakaki C, Boulamatsis D, Mariolis A et al. Use of cancer screening services in Greece and associated social factors: results from the nationwide Hellas Health I Survey. Eur J Cancer Prev 2009; 18: 248-257
- 17 Rauscher GH, Johnson TP, Cho YI et al. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17: 748-757
- 18 Griffin JM, Burgess D, Vernon SW et al. Are gender differences in colorectal cancer screening rates due to differences in self-reporting?. Prev Med 2009; 49: 436-441
- 19 Payne S. Not an equal opportunity disease – a sex and gender-based review of colorectal cancer in men and women: Part II. J Mens Health Gend 2007; 4: 131-139
- 20 Marbet UA, Bauerfeind P, Brunner J et al. Colonoscopy is the preferred colorectal cancer screening method in a population-based program. Endoscopy 2008; 40: 650-655
- 21 Beydoun HA, Beydoun MA. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control 2008; 19: 339-359
- 22 von Euler-Chelpin M, Brasso K, Lynge E. Determinants of participation in colorectal cancer screening with fecal occult blood testing. J Public Health (Oxf) 2009; 32: 395-405
- 23 Weinberg DS, Turner BJ, Wang H et al. A Survey of women regarding factors affecting colorectal cancer screening compliance. Prev Med 2004; 38: 669-675
- 24 Ackermann-Liebrich U, Zemp Stutz E. Geschlechterfragen in der Medizin. In: Buddenberg C, ed. Psychosoziale Medizin. Berlin, Heidelberg: Springer-Verlag; 2004: 363-372